Single Source for the Continuation of the Human Pancreas Analysis Program (HPAP) for Type 1 Diabetes (HPAP-T1D) (U01 Clinical Trial Not Allowed)
ID: 354719Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $6M

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/354719

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-25-012.html
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Jun 5, 2024 12:00 AM
  4. 4
    Due Oct 24, 2024 12:00 AM
Description

The National Institutes of Health (NIH) has posted a grant opportunity titled "Single Source for the Continuation of the Human Pancreas Analysis Program (HPAP) for Type 1 Diabetes (HPAP-T1D) (U01 Clinical Trial Not Allowed)". This funding opportunity falls under the category of Health and is a discretionary grant. The grant is a cooperative agreement and does not require cost sharing or matching. The deadline for applications is October 24, 2024.

The purpose of this grant is to provide funding for the continuation of the Human Pancreas Analysis Program for Type 1 Diabetes (HPAP-T1D). The University of Pennsylvania has been identified as the recipient of this single source cooperative agreement. The program aims to identify, collect, and characterize primary pancreatic tissues and immune cells from patients with type 1 diabetes (T1D) or at risk of developing the disease, as well as age-matched controls. The collected data will be analyzed, organized, and shared through the existing PANC DB open-access resource database. The program is part of the Human Islet Research Network (HIRN), which focuses on understanding the loss of human beta cells in T1D and finding strategies to protect and replace functional human beta cell mass.

Small businesses and other eligible applicants are invited to apply for this grant opportunity. Non-domestic (non-U.S.) entities and components of U.S. organizations are not eligible to apply. For more information on eligibility, please refer to the full Notice of Funding Opportunity. The maximum award ceiling for this grant is $5,500,000.

For further details and to apply, interested parties can visit the following website: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-25-012.html. If there are any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.

Point(s) of Contact
grantsinfo@nih.gov
Files
Title
Posted
RFA-DK-25-012-Full-Announcement.html
6/06/2024
Similar Opportunities
Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)
Active
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)". This grant aims to provide support for the TrialNet Coordinating Center (TNCC), which plays a crucial role in identifying individuals with type 1 diabetes (T1D) and enrolling them in trials and studies focused on preventing disease progression and preserving insulin production. The TNCC will be responsible for various research projects at different stages of development, implementation, and completion. Additionally, it will handle data and sample management, including acquisition, quality control, dissemination, and public accessibility. The TNCC will also oversee network administration and operations, including the evaluation, selection, and funding of Clinical Centers and central support units. Applicants for this grant should include a Plan for Enhancing Diverse Perspectives (PEDP), which will be evaluated as part of the scientific and technical peer review process. Failure to include a PEDP will result in the application being considered incomplete and withdrawn. For more information and detailed instructions, interested parties can visit the following website: [http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-25-004.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-25-004.html). If you have any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.
NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)". This cooperative agreement aims to support investigator-initiated, high-risk multi-center clinical trials that have the potential to change clinical practice and/or public health. The trials should be hypothesis-driven and focus on a disease relevant to the mission of NIDDK. The grant does not require cost sharing or matching. It falls under the category of funding activity related to health. The eligible applicants include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments, Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. However, non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply. The grant opportunity requires the completion of planning activities prior to submission. Applicants who require a planning phase may first apply for an implementation planning cooperative agreement (U34). It is strongly encouraged to consult with NIDDK Scientific/Research staff before submitting either a U34 or U01 application. The deadline for application submission is November 5, 2026. For more information and to apply, interested parties can visit the following website: [http://grants.nih.gov/grants/guide/pa-files/PAR-24-103.html](http://grants.nih.gov/grants/guide/pa-files/PAR-24-103.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed)". This cooperative agreement aims to support investigator-initiated, high-risk multi-center observational studies involving more than one clinical center. The proposed studies should be hypothesis-driven and focus on a disease relevant to the mission of NIDDK. The grant does not require cost sharing or matching requirements and falls under the category of funding activity for health. The eligible applicants include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. However, non-domestic (non-U.S.) Entities (Foreign Organizations) and non-domestic components of U.S. Organizations are not eligible to apply. The grant opportunity does not allow planning activities and applicants who require a planning phase may first apply for an implementation planning cooperative agreement (U34). It is strongly encouraged for applicants to consult with NIDDK Scientific/Research staff prior to the submission of either a U34 or U01 application. The closing date for this grant opportunity is November 5, 2026, and the archive date is December 11, 2026. For more information and to apply, interested parties can visit the following website: [http://grants.nih.gov/grants/guide/pa-files/PAR-24-102.html](http://grants.nih.gov/grants/guide/pa-files/PAR-24-102.html). For any inquiries, the contact email is grantsinfo@nih.gov.
NIDDK Education Program Grants (R25 Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering NIDDK Education Program Grants through a Grant opportunity titled "NIDDK Education Program Grants (R25 Clinical Trial Not Allowed)". This grant opportunity falls under the category of Health and is posted on grants.gov. The purpose of this grant is to support educational activities that complement and enhance the training of a workforce to meet the nation's biomedical, behavioral, and clinical research needs. The NIDDK Education Program Grants will primarily focus on two areas: courses for skills development and research experiences. These educational activities must align with NIDDK's mission areas, which include diabetes and other endocrine and metabolic diseases, digestive diseases, nutritional disorders, obesity, and kidney, urologic, and hematologic diseases. The grant does not require cost sharing or matching requirements. The funding instrument type is a Grant, and the opportunity category is Discretionary. The CFDA number associated with this grant is 93.847. Eligible applicants for this grant include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the Federal Government, faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), regional organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply. The closing date for this grant opportunity is January 30, 2026. The award ceiling is $100,000. The grant description and additional information can be found on the NIH website at [http://grants.nih.gov/grants/guide/pa-files/PAR-24-074.html](http://grants.nih.gov/grants/guide/pa-files/PAR-24-074.html). For any inquiries or further information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (R01 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (R01 Clinical Trial Optional)". This grant aims to support innovative multidisciplinary and multi-level research to develop and/or test interventions for optimizing care of individuals with Type 2 diabetes from populations with health/healthcare disparities. The target populations include racial and ethnic minorities, sexual and gender minorities, socioeconomically disadvantaged populations, and underserved rural populations. The proposed projects should focus on patient-centered strategies that aim to achieve optimal glycemic control and complete other recommended guidelines, such as annual eye/foot and urine albumin exams, optimal blood pressure control, intake of ACEIs or ARBs/statin/aspirin, and influenza/pneumonia vaccines. The grant does not require cost sharing or matching. The maximum award ceiling is $500,000. Other eligible applicants, in addition to U.S. organizations, include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments, regional organizations, and Tribally Controlled Colleges and Universities (TCCUs). Non-domestic (non-U.S.) entities and components are not eligible to apply. The closing date for applications is September 7, 2024. For more information, visit the [grant announcement](http://grants.nih.gov/grants/guide/pa-files/PA-21-232.html). For any issues or inquiries, contact the NIH OER Webmaster at grantsinfo@nih.gov.